Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
ALISO VIEJO, Calif., Sept. 20, 2016 -- NVISION Eye Centers—a national leader in providing the finest suite of ophthalmology services for patients including: custom and Topo-guided LASIK, KAMRA Inlay, cataract surgery and other vision correction procedures— is pleased to introduce the Symfony Lens to its product offerings. NVISION Eye Centers offers an array of lifestyle lenses for cataract patients and has started placing the FDA-approved lens for its patients in California, Arizona, Oregon, and Nevada.
"The Symfony lens is an advancement in lens technology that provides cataract patients with crisp and clear near, intermediate and distance vision, even if the patient has an astigmatism,” says NVISION Eye Centers' medical director, Dr. Jeff Machat, who oversees and trains the company’s team of surgeons on new technologies including best practices, techniques, and pre- and post observations. "NVISION’s Crystal Clear Vision center in Toronto, Canada has been successfully placing the Symfony lens for its Canadian patients for several years, and we are thrilled to be able to now offer such a well-studied, finely-tuned device to our patients in the United States."
The Symfony lens is the only intraocular lens in the United States that provides a full range of continuous vision following cataract surgery, while also mitigating the effects of presbyopia, or near vision loss. Patients needing to rid themselves of the cloudiness, caused by cataracts, can also eliminate the need for distance or reading glasses in one procedure with the revolutionary Symfony Lens or its counterpart—the Symfony Toric —for cataract patients with astigmatism.
For more information, or to schedule a consultation, call (877) 455-9942 or visit: https://nvisioncenters.com/procedures/laser-cataract-surgery.
ABOUT NVISION EYE CENTERS: NVISION Eye Centers is the premier provider of LASIK and cataract surgery in the U.S., with centers in California, Nevada, Oregon, Arizona and Toronto, Canada. An innovative leader in ophthalmology, NVISION is dedicated to providing the best patient experience through the use of the latest technology and treatment by the most talented and experienced surgeons in the industry. NVISION was founded in 2010 by Tom Tooma, M.D., one of the earliest pioneers of LASIK who has performed more than 100,000 procedures throughout his esteemed career. With more than 1,900 eye doctors referring their patients and trusting their own eyes to NVISION surgeons, NVISION Eye Centers is the Eye Doctors' #1 Choice®. For more information, visit www.NVISIONCenters.com or call (877) 455-9942.
